Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M-4 muscarinic acetylcholine receptor knockout mice

Citation
J. Gomeza et al., Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M-4 muscarinic acetylcholine receptor knockout mice, P NAS US, 96(18), 1999, pp. 10483-10488
Citations number
41
Categorie Soggetti
Multidisciplinary
Journal title
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
ISSN journal
00278424 → ACNP
Volume
96
Issue
18
Year of publication
1999
Pages
10483 - 10488
Database
ISI
SICI code
0027-8424(19990831)96:18<10483:EODDRL>2.0.ZU;2-O
Abstract
Muscarinic acetylcholine receptors (M-1-M-5) regulate many key functions of the central and peripheral nervous system. Primarily because of the lack o f receptor subtype-selective ligands, the precise physiological roles of th e individual muscarinic receptor subtypes remain to be elucidated; Interest ingly, the M-4 receptor subtype is expressed abundantly in the striatum and various other forebrain regions. To study its potential role in the regula tion of locomotor activity and other central functions, we used gene-target ing technology to create mice that lack functional M-4 receptors. Pharmacol ogic analysis of M-4 receptor-deficient mice indicated that M-4 receptors a re not required for muscarinic receptor-mediated analgesia, tremor, hypothe rmia, and salivation. Strikingly, M-4 receptor-deficient mice showed an inc rease in basal locomotor activity and greatly enhanced locomotor responses (as compared with their wild-type littermates) after activation of D1 dopam ine receptors. These results indicate that M-4 receptors exert inhibitory c ontrol on D1 receptor-mediated locomotor stimulation, probably at the level of striatal projection neurons where the two receptors are coexpressed at high levels. Our findings offer new perspectives for the treatment of Parki nson's disease and other movement disorders that are characterized by an im balance between muscarinic cholinergic and dopaminergic neurotransmission.